LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94808-3 | COVID-19+Intubation+Consultation note | Find | Pt | {Setting} | Doc | Resident | DOC.ONTOLOGY | 2 | Resident COVID-19 Intubation Consultation note | Res COVID-19 Intub+Consult | null | ACTIVE | 2.68 | 2.7 |
94809-1 | COVID-19+Intubation+Progress note | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID-19 Intubation Progress note | COVID-19 Intub+Progress | null | ACTIVE | 2.68 | 2.7 |
94810-9 | COVID-19+Intubation+Procedure note | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID-19 Intubation Procedure note | COVID-19 Intub Proced | null | ACTIVE | 2.68 | 2.7 |
94811-7 | COVID-19+Intubation+Evaluation note | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID-19 Intubation Evaluation note | COVID-19 Intub Eval note | null | ACTIVE | 2.68 | 2.7 |
94812-5 | COVID-19+Intubation+Cardiopulmonary resuscitation note | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID-19 Intubation and Cardiopulmonary resuscitation note | COVID-19 Intub+CPR | null | ACTIVE | 2.68 | 2.7 |
9481-3 | pH | LsCnc | Pt | Water | Qn | null | CHEM | 1 | pH of Water | pH Wat | null | ACTIVE | 1.0i | 2.42 |
94813-3 | COVID-19+Intubation+Conference note | Find | Pt | {Setting} | Doc | Team | DOC.ONTOLOGY | 2 | Team COVID-19 Intubation Conference note | Team COVID-19 Intub Conference | null | ACTIVE | 2.68 | 2.7 |
94814-1 | COVID-19+Consultation note | Find | Pt | {Setting} | Doc | Critical Care Medicine | DOC.ONTOLOGY | 2 | Critical care medicine COVID-19 Consultation note | CCM COVID-19 Consult note | null | ACTIVE | 2.68 | 2.7 |
94815-8 | CV2 Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | CV2 IgG Ab [Titer] in Serum by Immunofluorescence | CV2 IgG Titr Ser IF | null | ACTIVE | 2.68 | 2.68 |
94816-6 | Voltage-gated potassium channel Ab | SCnc | Pt | Ser | Qn | IA | SERO | 1 | Voltage-gated potassium channel Ab [Moles/volume] in Serum by Immunoassay | VGKC Ab Ser IA-sCnc | null | ACTIVE | 2.68 | 2.68 |
94817-4 | Striated muscle Ab | Titr | Pt | Ser | Qn | IA | SERO | 1 | Striated muscle Ab [Titer] in Serum by Immunoassay | Stria Mus Ab Titr Ser IA | null | ACTIVE | 2.68 | 2.68 |
94818-2 | Paraneoplastic Ab panel | - | Pt | CSF | - | IF | PANEL.SERO | 1 | Paraneoplastic Ab panel - Cerebral spinal fluid by Immunofluorescence | Paraneoplastic Ab Pnl CSF IF | null | ACTIVE | 2.68 | 2.68 |
94819-0 | SARS coronavirus 2 RNA | LnCnc | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | SARS-CoV-2 RNA Spec NAA+probe-Log# | null | ACTIVE | 2.68 | 2.69 |
94820-8 | Whole mRNA transcriptome sequence analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | Whole mRNA transcriptome sequence analysis in Blood or Tissue by Sequencing | Whole mRNA Seq Analysis Bld/T Seq | null | ACTIVE | 2.68 | 2.68 |
9482-1 | Potassium | MCnc | Pt | Water | Qn | null | CHEM | 1 | Potassium [Mass/volume] in Water | Potassium Wat-mCnc | null | ACTIVE | 1.0i | 2.7 |
94821-6 | COVID-19+Intubation advance directives | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID-19 Intubation advance directives | COVID-19 Intubation Adv Dir | null | ACTIVE | 2.68 | 2.7 |
94822-4 | SARS coronavirus 2 RNA | PrThr | Pt | Saliva | Ord | Sequencing | MICRO | 1 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing | SARS-CoV-2 RNA Sal Ql Seq | null | ACTIVE | 2.68 | 2.69 |
94823-2 | Cytomegalovirus DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Cytomegalovirus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | CMV DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94824-0 | Parvovirus B19 DNA | ACnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Parvovirus B19 DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection | B19V DNA Amn NAA+probe-aCnc | null | ACTIVE | 2.68 | 2.68 |
94825-7 | Parvovirus B19 DNA | LaCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Parvovirus B19 DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection | B19V DNA Amn NAA+probe-Log IU | null | ACTIVE | 2.68 | 2.68 |
94826-5 | Parvovirus B19 DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | B19V DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94827-3 | Epstein Barr virus DNA | PrThr | Pt | Amnio fld | Ord | Probe.amp.tar | MICRO | 1 | Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection | EBV DNA Amn Ql NAA+probe | null | ACTIVE | 2.68 | 2.68 |
94828-1 | Epstein Barr virus DNA | ACnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Epstein Barr virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection | EBV DNA Amn NAA+probe-aCnc | null | ACTIVE | 2.68 | 2.68 |
94829-9 | Epstein Barr virus DNA | LaCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Epstein Barr virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection | EBV DNA Amn NAA+probe-Log IU | null | ACTIVE | 2.68 | 2.68 |
94830-7 | Epstein Barr virus DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Epstein Barr virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | EBV DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94831-5 | Varicella zoster virus DNA | ACnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Varicella zoster virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection | VZV DNA Amn NAA+probe-aCnc | null | ACTIVE | 2.68 | 2.68 |
94832-3 | Varicella zoster virus DNA | LaCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Varicella zoster virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection | VZV DNA Amn NAA+probe-Log IU | null | ACTIVE | 2.68 | 2.68 |
94833-1 | Varicella zoster virus DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Varicella zoster virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | VZV DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94834-9 | Herpes simplex virus 1+2 DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Herpes simplex virus 1+2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | HSV1+2 DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94835-6 | Herpes simplex virus 1 DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Herpes simplex virus 1 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | HSV1 DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94836-4 | Herpes simplex virus 2 DNA | LnCnc | Pt | Amnio fld | Qn | Probe.amp.tar | MICRO | 1 | Herpes simplex virus 2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | HSV2 DNA Amn NAA+probe-Log# | null | ACTIVE | 2.68 | 2.68 |
94837-2 | Dengue virus 1+2+3+4 RNA | PrThr | Pt | Amnio fld | Ord | Probe.amp.tar | MICRO | 1 | Dengue virus 1+2+3+4 RNA [Presence] in Amniotic fluid by NAA with probe detection | DENV1+2+3+4 RNA Amn Ql NAA+probe | null | ACTIVE | 2.68 | 2.68 |
94838-0 | Enterovirus RNA | PrThr | Pt | Amnio fld | Ord | Probe.amp.tar | MICRO | 1 | Enterovirus RNA [Presence] in Amniotic fluid by NAA with probe detection | EV RNA Amn Ql NAA+probe | null | ACTIVE | 2.68 | 2.68 |
9483-9 | Selenium | MCnc | Pt | Water | Qn | null | DRUG/TOX | 1 | Selenium [Mass/volume] in Water | Selenium Wat-mCnc | null | ACTIVE | 1.0i | 2.7 |
94839-8 | Calcium | MCnc | Pt | Urine^Fetus | Qn | null | CHEM | 1 | Calcium [Mass/volume] in Urine from Fetus | Calcium Ur Fetus-mCnc | null | ACTIVE | 2.68 | 2.68 |
94840-6 | Chloride | SCnc | Pt | Urine^Fetus | Qn | null | CHEM | 1 | Chloride [Moles/volume] in Urine from Fetus | Chloride Ur Fetus-sCnc | null | ACTIVE | 2.68 | 2.68 |
94841-4 | Potassium | SCnc | Pt | Urine^Fetus | Qn | null | CHEM | 1 | Potassium [Moles/volume] in Urine from Fetus | Potassium Ur Fetus-sCnc | null | ACTIVE | 2.68 | 2.68 |
94842-2 | Sodium | SCnc | Pt | Urine^Fetus | Qn | null | CHEM | 1 | Sodium [Moles/volume] in Urine from Fetus | Sodium Ur Fetus-sCnc | null | ACTIVE | 2.68 | 2.68 |
94843-0 | Osmolality | Osmol | Pt | Urine^Fetus | Qn | null | CHEM | 1 | Osmolality of Urine from Fetus | Osmolality Ur Fetus | null | ACTIVE | 2.68 | 2.68 |
94844-8 | Creatinine | MCnc | Pt | Urine^Fetus | Qn | null | CHEM | 1 | Creatinine [Mass/volume] in Urine from Fetus | Creat Ur Fetus-mCnc | null | ACTIVE | 2.68 | 2.68 |
94845-5 | SARS coronavirus 2 RNA | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 RNA Sal Ql NAA+probe | null | ACTIVE | 2.68 | 2.69 |
94846-3 | Specimen collection problem | Hx | Pt | ^Patient | Nom | null | H&P.HX | 2 | History of Specimen collection problem | Hx of Spec collection problem | null | ACTIVE | 2.68 | 2.68 |
9484-7 | Silver | MCnc | Pt | Water | Qn | null | DRUG/TOX | 1 | Silver [Mass/volume] in Water | Silver Wat-mCnc | null | ACTIVE | 1.0i | 2.7 |
94847-1 | Reason specimen not collected | Find | Pt | Specimen | Nom | null | SPEC | 1 | Reason specimen not collected | Reason spec not collected | null | ACTIVE | 2.68 | 2.68 |
94848-9 | Functional assessment standardized items (FASI) - version 1.0 | - | - | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | Functional assessment standardized items (FASI) - version 1.0 [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94849-7 | FASI v1.0 - Self-care - usual performance | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | FASI v1.0 - Self-care - usual performance during assessment period [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.69 |
94850-5 | FASI v1.0 - Self-care - most dependent performance | - | 1Mo | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | FASI v1.0 - Self-care - most dependent performance [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94851-3 | FASI v1.0 - Mobility - usual performance | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | FASI v1.0 - Mobility - usual performance during assessment period [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.69 |
94852-1 | FASI v1.0 - Mobility - most dependent performance | - | 1Mo | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | FASI v1.0 - Mobility - most dependent performance [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94853-9 | West Nile virus Ab.IgG & IgM panel | - | Pt | CSF | Ord | null | PANEL.MICRO | 1 | West Nile virus IgG and IgM panel - Cerebral spinal fluid Qualitative | WNV IgG+IgM Pnl CSF | null | ACTIVE | 2.68 | 2.68 |
9485-4 | Sodium | MCnc | Pt | Water | Qn | null | CHEM | 1 | Sodium [Mass/volume] in Water | Sodium Wat-mCnc | null | ACTIVE | 1.0i | 2.7 |
94854-7 | West Nile virus Ab.IgG & IgM panel | - | Pt | Ser | Ord | null | PANEL.MICRO | 1 | West Nile virus IgG and IgM panel - Serum Qualitative | WNV IgG+IgM Pnl Ser | null | ACTIVE | 2.68 | 2.68 |
94855-4 | Carbamazepine hypersensitivity genotype panel | - | Pt | Bld/Tiss | - | null | PANEL.MOLPATH.PHARMG | 1 | carBAMazepine hypersensitivity genotype panel - Blood or Tissue | carBAMazepine hypersens geno Pnl Bld/T | null | ACTIVE | 2.68 | 2.68 |
94856-2 | Microscopic observation^2nd specimen | PrThr | Pt | Sputum | Ord | Acid fast stain | MICRO | 1 | Microscopic observation [Presence] in Sputum by Acid fast stain --2nd specimen | Acid fast Stn sp2 Spt Ql | null | ACTIVE | 2.68 | 2.68 |
94857-0 | Microscopic observation^3rd specimen | PrThr | Pt | Sputum | Ord | Acid fast stain | MICRO | 1 | Microscopic observation [Presence] in Sputum by Acid fast stain --3rd specimen | Acid fast Stn sp3 Spt Ql | null | ACTIVE | 2.68 | 2.68 |
94858-8 | Glycerol | SCnc | Pt | Ser | Qn | Calculated | CHEM | 1 | Glycerol [Moles/volume] in Serum by calculation | Glycerol Ser Calc-sCnc | null | ACTIVE | 2.68 | 2.68 |
94859-6 | Glycerol & Glycerol-corrected triglyceride panel | - | Pt | Ser/Plas | - | null | PANEL.CHEM | 1 | Glycerol and glycerol-corrected triglyceride panel - Serum or Plasma | Glycerol + glycerol corr TG Pnl SerPl | null | ACTIVE | 2.68 | 2.68 |
94860-4 | Transthyretin | Mass | Pt | Bld | Qn | null | CHEM | 1 | Transthyretin [Mass] in Blood | TTR Bld Qn | null | ACTIVE | 2.68 | 2.68 |
94861-2 | Transthyretin - transthyretin peak 2 | MDiff | Pt | Bld | Qn | null | CHEM | 1 | Transthyretin - transthyretin peak 2 [Mass difference] in Blood | TTR - TTR 2 MDiff Bld | null | ACTIVE | 2.68 | 2.68 |
9486-2 | Sulfate | MCnc | Pt | Water | Qn | null | CHEM | 1 | Sulfate [Mass/volume] in Water | Sulfate Wat-mCnc | null | ACTIVE | 1.0i | 2.7 |
94862-0 | Transthyretin peak 2 | Mass | Pt | Bld | Qn | null | CHEM | 1 | Transthyretin peak 2 [Mass] in Blood | TTR 2 Bld Qn | null | ACTIVE | 2.68 | 2.68 |
94863-8 | Transthyretin width at half peak height | Mass | Pt | Bld | Qn | null | CHEM | 1 | Transthyretin width at half peak height [Mass] in Blood | TTR width at half height Bld Qn | null | ACTIVE | 2.68 | 2.68 |
94864-6 | Transthyretin-associated familial amyloidosis panel | - | Pt | Bld | - | null | PANEL.CHEM | 1 | Transthyretin-associated familial amyloidosis panel - Blood | TTR-assoc familial amyloidosis Pnl Bld | null | ACTIVE | 2.68 | 2.68 |
94865-3 | Triglyceride^^corrected for glycerol | MCnc | Pt | Ser | Qn | null | CHEM | 1 | Triglyceride [Mass/volume] corrected for glycerol in Serum | Trigl Glycer cor Ser-mCnc | null | ACTIVE | 2.68 | 2.68 |
94866-1 | 7-Alpha hydroxy-4-cholesten-3-one | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 7-Alpha hydroxy-4-cholesten-3-one [Mass/volume] in Serum or Plasma | 7a-OH-4-chol-3-one SerPl-mCnc | null | ACTIVE | 2.68 | 2.68 |
94867-9 | Ganglioside GD1b Ab.IgG | Titr | Pt | Ser | Qn | IA | SERO | 1 | Ganglioside GD1b IgG Ab [Titer] in Serum by Immunoassay | GD1b Gangl IgG Titr Ser IA | null | ACTIVE | 2.68 | 2.68 |
94868-7 | Ganglioside GD1b Ab.IgG | PrThr | Pt | Ser | Ord | IA | SERO | 1 | Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoassay | GD1b Gangl IgG Ser Ql IA | null | ACTIVE | 2.68 | 2.68 |
94869-5 | Ganglioside GD1b Ab.IgM | Titr | Pt | Ser | Qn | IA | SERO | 1 | Ganglioside GD1b IgM Ab [Titer] in Serum by Immunoassay | GD1b Gangl IgM Titr Ser IA | null | ACTIVE | 2.68 | 2.68 |
9487-0 | Zinc | MCnc | Pt | Water | Qn | null | DRUG/TOX | 1 | Zinc [Mass/volume] in Water | Zinc Wat-mCnc | null | ACTIVE | 1.0i | 2.7 |
94870-3 | Ganglioside GD1b Ab.IgM | PrThr | Pt | Ser | Ord | IA | SERO | 1 | Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoassay | GD1b Gangl IgM Ser Ql IA | null | ACTIVE | 2.68 | 2.68 |
94871-1 | Aldosterone & sodium panel | - | 24H | Urine | Qn | null | PANEL.CHEM | 1 | Aldosterone and sodium panel - 24 hour Urine | Aldosterone + Na Pnl 24h Ur | null | ACTIVE | 2.68 | 2.68 |
94872-9 | Cholesterol & triglyceride panel | - | Pt | Body fld | Qn | null | PANEL.CHEM | 1 | Cholesterol and triglyceride panel - Body fluid | Chol + Trigl Pnl Fld | null | ACTIVE | 2.68 | 2.68 |
94873-7 | Cortisol.free post corticotropin stimulation panel | - | Pt | Ser/Plas | Qn | null | PANEL.CHAL | 1 | Cortisol.free post corticotropin stimulation panel - Serum or Plasma | Cortis F p corticotropin stim Pnl SerPl | null | ACTIVE | 2.68 | 2.68 |
94874-5 | Cyclic citrullinated peptide Ab.IgG | ACnc | Pt | Ser/Plas | Qn | IA | SERO | 1 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | cCP IgG SerPl IA-aCnc | null | ACTIVE | 2.68 | 2.68 |
94875-2 | Nuclear Ab.IgG | ACnc | Pt | Ser/Plas | Qn | IA | SERO | 1 | Nuclear IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | Nuclear IgG SerPl IA-aCnc | null | ACTIVE | 2.68 | 2.68 |
94876-0 | Self-care priorities for the next 6Mo | Find | Pt | ^Patient | Nar | CMS Assessment | SURVEY.CMS | 4 | Self-care priorities for the next 6 months [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94877-8 | Mobility priorities for the next 6Mo | Find | Pt | ^Patient | Nar | CMS Assessment | SURVEY.CMS | 4 | Mobility priorities for the next 6 months [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94878-6 | Instrumental activities of daily living priorities for the next 6Mo | Find | Pt | ^Patient | Nar | CMS Assessment | SURVEY.CMS | 4 | Instrumental activities of daily living priorities for the next 6 months [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94879-4 | Need for and availability of a cane &or crutch | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a cane/crutch [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94880-2 | Need for and availability of a walker | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a walker [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94881-0 | Need for and availability of a standard folding walker | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a standard folding walker [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94882-8 | Need for and availability of a walker with seat | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a walker with seat [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94883-6 | Need for and availability of a walker with wheels | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a walker with wheels [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94884-4 | Need for and availability of a wheelchair | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a wheelchair [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94885-1 | Need for and availability of a manual wheelchair | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a manual wheelchair [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94886-9 | Need for and availability of a motorized wheelchair &or scooter | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a motorized wheelchair/scooter [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94887-7 | Need for and availability of a limb prosthesis | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a limb prosthesis [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94888-5 | Need for and availability of a specialized seating pad | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a specialized seating pad [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94889-3 | Need for and availability of a mechanical lift | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a mechanical lift [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94890-1 | Need for and availability of a reacher &or grabber | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a reacher/grabber [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94891-9 | Need for and availability of a sock aid | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a sock aid [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94892-7 | Need for and availability of an orthotic &or brace | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of an orthotic/brace [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94893-5 | Need for and availability of a bed rail | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a bed rail [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94894-3 | Need for and availability of an electronic bed | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of an electronic bed [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94895-0 | Need for and availability of grab bars | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of grab bars [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
9489-6 | Arsenic | MCnc | Pt | Body fld | Qn | null | DRUG/TOX | 1 | Arsenic [Mass/volume] in Body fluid | Arsenic Fld-mCnc | null | ACTIVE | 1.0i | 2.34 |
94896-8 | Need for and availability of a transfer board | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a transfer board [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94897-6 | Need for and availability of a shower &or commode chair | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a shower/commode chair [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94898-4 | Need for and availability of a walk or wheel-in shower | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of a walk/wheel-in shower [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
94899-2 | Need for and availability of glasses or contact lenses | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Need for and availability of glasses or contact lenses [CMS Assessment] | null | null | ACTIVE | 2.68 | 2.68 |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.